Home > > > > Report Detail

Global Sheep and Goat Pox Vaccines Market Growth 2023-2029

Publisher Name :
Date: 01-Feb-2023
No. of pages: 102

A single vaccine against sheep and goat pox (capripox) has been developed to protect sheep and goats throughout the capripox enzootic area.

LPI (LP Information)' newest research report, the "Sheep and Goat Pox Vaccines Industry Forecast" looks at past sales and reviews total world Sheep and Goat Pox Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Sheep and Goat Pox Vaccines sales for 2023 through 2029. With Sheep and Goat Pox Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sheep and Goat Pox Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Sheep and Goat Pox Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sheep and Goat Pox Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Sheep and Goat Pox Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sheep and Goat Pox Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sheep and Goat Pox Vaccines.

The global Sheep and Goat Pox Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Sheep and Goat Pox Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Sheep and Goat Pox Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Sheep and Goat Pox Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Sheep and Goat Pox Vaccines players cover Agrovet, Biopharma, Dollvet, FGBI - Federal Centre for Animal Health, Hester Biosciences Limited, Indian Immunologicals Limited, Institut Pasteur d'Algerie, Intervac (PVT) Ltd. and JOVAC, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Sheep and Goat Pox Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Live Vaccines

- Killed Vaccines

Segmentation by application

- Sheep

- Goat

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Agrovet

- Biopharma

- Dollvet

- FGBI - Federal Centre for Animal Health

- Hester Biosciences Limited

- Indian Immunologicals Limited

- Institut Pasteur d'Algerie

- Intervac (PVT) Ltd.

- JOVAC

- Tiankang Biopharmacuetical

- Vetal Company

- Veterinary Research Institute

Key Questions Addressed in this Report

What is the 10-year outlook for the global Sheep and Goat Pox Vaccines market?

What factors are driving Sheep and Goat Pox Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Sheep and Goat Pox Vaccines market opportunities vary by end market size?

How does Sheep and Goat Pox Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Sheep and Goat Pox Vaccines Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sheep and Goat Pox Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sheep and Goat Pox Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sheep and Goat Pox Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Sheep and Goat Pox Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Sheep and Goat Pox Vaccines Sales by Type
2.3.1 Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Sheep and Goat Pox Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sheep and Goat Pox Vaccines Sale Price by Type (2018-2023)
2.4 Sheep and Goat Pox Vaccines Segment by Application
2.4.1 Sheep
2.4.2 Goat
2.5 Sheep and Goat Pox Vaccines Sales by Application
2.5.1 Global Sheep and Goat Pox Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Sheep and Goat Pox Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sheep and Goat Pox Vaccines Sale Price by Application (2018-2023)
3 Global Sheep and Goat Pox Vaccines by Company
3.1 Global Sheep and Goat Pox Vaccines Breakdown Data by Company
3.1.1 Global Sheep and Goat Pox Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Sheep and Goat Pox Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Sheep and Goat Pox Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Sheep and Goat Pox Vaccines Revenue by Company (2018-2023)
3.2.2 Global Sheep and Goat Pox Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Sheep and Goat Pox Vaccines Sale Price by Company
3.4 Key Manufacturers Sheep and Goat Pox Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sheep and Goat Pox Vaccines Product Location Distribution
3.4.2 Players Sheep and Goat Pox Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sheep and Goat Pox Vaccines by Geographic Region
4.1 World Historic Sheep and Goat Pox Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Sheep and Goat Pox Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sheep and Goat Pox Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sheep and Goat Pox Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Sheep and Goat Pox Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sheep and Goat Pox Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sheep and Goat Pox Vaccines Sales Growth
4.4 APAC Sheep and Goat Pox Vaccines Sales Growth
4.5 Europe Sheep and Goat Pox Vaccines Sales Growth
4.6 Middle East & Africa Sheep and Goat Pox Vaccines Sales Growth
5 Americas
5.1 Americas Sheep and Goat Pox Vaccines Sales by Country
5.1.1 Americas Sheep and Goat Pox Vaccines Sales by Country (2018-2023)
5.1.2 Americas Sheep and Goat Pox Vaccines Revenue by Country (2018-2023)
5.2 Americas Sheep and Goat Pox Vaccines Sales by Type
5.3 Americas Sheep and Goat Pox Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sheep and Goat Pox Vaccines Sales by Region
6.1.1 APAC Sheep and Goat Pox Vaccines Sales by Region (2018-2023)
6.1.2 APAC Sheep and Goat Pox Vaccines Revenue by Region (2018-2023)
6.2 APAC Sheep and Goat Pox Vaccines Sales by Type
6.3 APAC Sheep and Goat Pox Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sheep and Goat Pox Vaccines by Country
7.1.1 Europe Sheep and Goat Pox Vaccines Sales by Country (2018-2023)
7.1.2 Europe Sheep and Goat Pox Vaccines Revenue by Country (2018-2023)
7.2 Europe Sheep and Goat Pox Vaccines Sales by Type
7.3 Europe Sheep and Goat Pox Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sheep and Goat Pox Vaccines by Country
8.1.1 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sheep and Goat Pox Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Type
8.3 Middle East & Africa Sheep and Goat Pox Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sheep and Goat Pox Vaccines
10.3 Manufacturing Process Analysis of Sheep and Goat Pox Vaccines
10.4 Industry Chain Structure of Sheep and Goat Pox Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sheep and Goat Pox Vaccines Distributors
11.3 Sheep and Goat Pox Vaccines Customer
12 World Forecast Review for Sheep and Goat Pox Vaccines by Geographic Region
12.1 Global Sheep and Goat Pox Vaccines Market Size Forecast by Region
12.1.1 Global Sheep and Goat Pox Vaccines Forecast by Region (2024-2029)
12.1.2 Global Sheep and Goat Pox Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sheep and Goat Pox Vaccines Forecast by Type
12.7 Global Sheep and Goat Pox Vaccines Forecast by Application
13 Key Players Analysis
13.1 Agrovet
13.1.1 Agrovet Company Information
13.1.2 Agrovet Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.1.3 Agrovet Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Agrovet Main Business Overview
13.1.5 Agrovet Latest Developments
13.2 Biopharma
13.2.1 Biopharma Company Information
13.2.2 Biopharma Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.2.3 Biopharma Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Biopharma Main Business Overview
13.2.5 Biopharma Latest Developments
13.3 Dollvet
13.3.1 Dollvet Company Information
13.3.2 Dollvet Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.3.3 Dollvet Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Dollvet Main Business Overview
13.3.5 Dollvet Latest Developments
13.4 FGBI - Federal Centre for Animal Health
13.4.1 FGBI - Federal Centre for Animal Health Company Information
13.4.2 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.4.3 FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 FGBI - Federal Centre for Animal Health Main Business Overview
13.4.5 FGBI - Federal Centre for Animal Health Latest Developments
13.5 Hester Biosciences Limited
13.5.1 Hester Biosciences Limited Company Information
13.5.2 Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.5.3 Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hester Biosciences Limited Main Business Overview
13.5.5 Hester Biosciences Limited Latest Developments
13.6 Indian Immunologicals Limited
13.6.1 Indian Immunologicals Limited Company Information
13.6.2 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.6.3 Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Indian Immunologicals Limited Main Business Overview
13.6.5 Indian Immunologicals Limited Latest Developments
13.7 Institut Pasteur d'Algerie
13.7.1 Institut Pasteur d'Algerie Company Information
13.7.2 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.7.3 Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Institut Pasteur d'Algerie Main Business Overview
13.7.5 Institut Pasteur d'Algerie Latest Developments
13.8 Intervac (PVT) Ltd.
13.8.1 Intervac (PVT) Ltd. Company Information
13.8.2 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.8.3 Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Intervac (PVT) Ltd. Main Business Overview
13.8.5 Intervac (PVT) Ltd. Latest Developments
13.9 JOVAC
13.9.1 JOVAC Company Information
13.9.2 JOVAC Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.9.3 JOVAC Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 JOVAC Main Business Overview
13.9.5 JOVAC Latest Developments
13.10 Tiankang Biopharmacuetical
13.10.1 Tiankang Biopharmacuetical Company Information
13.10.2 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.10.3 Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tiankang Biopharmacuetical Main Business Overview
13.10.5 Tiankang Biopharmacuetical Latest Developments
13.11 Vetal Company
13.11.1 Vetal Company Company Information
13.11.2 Vetal Company Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.11.3 Vetal Company Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Vetal Company Main Business Overview
13.11.5 Vetal Company Latest Developments
13.12 Veterinary Research Institute
13.12.1 Veterinary Research Institute Company Information
13.12.2 Veterinary Research Institute Sheep and Goat Pox Vaccines Product Portfolios and Specifications
13.12.3 Veterinary Research Institute Sheep and Goat Pox Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Veterinary Research Institute Main Business Overview
13.12.5 Veterinary Research Institute Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Sheep and Goat Pox Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sheep and Goat Pox Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Live Vaccines
Table 4. Major Players of Killed Vaccines
Table 5. Global Sheep and Goat Pox Vaccines Sales by Type (2018-2023) & (K Units)
Table 6. Global Sheep and Goat Pox Vaccines Sales Market Share by Type (2018-2023)
Table 7. Global Sheep and Goat Pox Vaccines Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2018-2023)
Table 9. Global Sheep and Goat Pox Vaccines Sale Price by Type (2018-2023) & (USD/Unit)
Table 10. Global Sheep and Goat Pox Vaccines Sales by Application (2018-2023) & (K Units)
Table 11. Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2018-2023)
Table 12. Global Sheep and Goat Pox Vaccines Revenue by Application (2018-2023)
Table 13. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application (2018-2023)
Table 14. Global Sheep and Goat Pox Vaccines Sale Price by Application (2018-2023) & (USD/Unit)
Table 15. Global Sheep and Goat Pox Vaccines Sales by Company (2018-2023) & (K Units)
Table 16. Global Sheep and Goat Pox Vaccines Sales Market Share by Company (2018-2023)
Table 17. Global Sheep and Goat Pox Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sheep and Goat Pox Vaccines Revenue Market Share by Company (2018-2023)
Table 19. Global Sheep and Goat Pox Vaccines Sale Price by Company (2018-2023) & (USD/Unit)
Table 20. Key Manufacturers Sheep and Goat Pox Vaccines Producing Area Distribution and Sales Area
Table 21. Players Sheep and Goat Pox Vaccines Products Offered
Table 22. Sheep and Goat Pox Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sheep and Goat Pox Vaccines Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Sheep and Goat Pox Vaccines Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sheep and Goat Pox Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sheep and Goat Pox Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sheep and Goat Pox Vaccines Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Sheep and Goat Pox Vaccines Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sheep and Goat Pox Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sheep and Goat Pox Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sheep and Goat Pox Vaccines Sales by Country (2018-2023) & (K Units)
Table 34. Americas Sheep and Goat Pox Vaccines Sales Market Share by Country (2018-2023)
Table 35. Americas Sheep and Goat Pox Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sheep and Goat Pox Vaccines Revenue Market Share by Country (2018-2023)
Table 37. Americas Sheep and Goat Pox Vaccines Sales by Type (2018-2023) & (K Units)
Table 38. Americas Sheep and Goat Pox Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. APAC Sheep and Goat Pox Vaccines Sales by Region (2018-2023) & (K Units)
Table 40. APAC Sheep and Goat Pox Vaccines Sales Market Share by Region (2018-2023)
Table 41. APAC Sheep and Goat Pox Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sheep and Goat Pox Vaccines Revenue Market Share by Region (2018-2023)
Table 43. APAC Sheep and Goat Pox Vaccines Sales by Type (2018-2023) & (K Units)
Table 44. APAC Sheep and Goat Pox Vaccines Sales by Application (2018-2023) & (K Units)
Table 45. Europe Sheep and Goat Pox Vaccines Sales by Country (2018-2023) & (K Units)
Table 46. Europe Sheep and Goat Pox Vaccines Sales Market Share by Country (2018-2023)
Table 47. Europe Sheep and Goat Pox Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sheep and Goat Pox Vaccines Revenue Market Share by Country (2018-2023)
Table 49. Europe Sheep and Goat Pox Vaccines Sales by Type (2018-2023) & (K Units)
Table 50. Europe Sheep and Goat Pox Vaccines Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sheep and Goat Pox Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sheep and Goat Pox Vaccines Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Sheep and Goat Pox Vaccines Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Sheep and Goat Pox Vaccines
Table 58. Key Market Challenges & Risks of Sheep and Goat Pox Vaccines
Table 59. Key Industry Trends of Sheep and Goat Pox Vaccines
Table 60. Sheep and Goat Pox Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sheep and Goat Pox Vaccines Distributors List
Table 63. Sheep and Goat Pox Vaccines Customer List
Table 64. Global Sheep and Goat Pox Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Sheep and Goat Pox Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sheep and Goat Pox Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Sheep and Goat Pox Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sheep and Goat Pox Vaccines Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Sheep and Goat Pox Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sheep and Goat Pox Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Sheep and Goat Pox Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sheep and Goat Pox Vaccines Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Sheep and Goat Pox Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sheep and Goat Pox Vaccines Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Sheep and Goat Pox Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sheep and Goat Pox Vaccines Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Sheep and Goat Pox Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Agrovet Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. Agrovet Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 80. Agrovet Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 81. Agrovet Main Business
Table 82. Agrovet Latest Developments
Table 83. Biopharma Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Biopharma Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 85. Biopharma Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 86. Biopharma Main Business
Table 87. Biopharma Latest Developments
Table 88. Dollvet Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Dollvet Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 90. Dollvet Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 91. Dollvet Main Business
Table 92. Dollvet Latest Developments
Table 93. FGBI - Federal Centre for Animal Health Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 95. FGBI - Federal Centre for Animal Health Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 96. FGBI - Federal Centre for Animal Health Main Business
Table 97. FGBI - Federal Centre for Animal Health Latest Developments
Table 98. Hester Biosciences Limited Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Hester Biosciences Limited Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 100. Hester Biosciences Limited Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 101. Hester Biosciences Limited Main Business
Table 102. Hester Biosciences Limited Latest Developments
Table 103. Indian Immunologicals Limited Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 105. Indian Immunologicals Limited Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 106. Indian Immunologicals Limited Main Business
Table 107. Indian Immunologicals Limited Latest Developments
Table 108. Institut Pasteur d'Algerie Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 110. Institut Pasteur d'Algerie Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. Institut Pasteur d'Algerie Main Business
Table 112. Institut Pasteur d'Algerie Latest Developments
Table 113. Intervac (PVT) Ltd. Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 115. Intervac (PVT) Ltd. Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Intervac (PVT) Ltd. Main Business
Table 117. Intervac (PVT) Ltd. Latest Developments
Table 118. JOVAC Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. JOVAC Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 120. JOVAC Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. JOVAC Main Business
Table 122. JOVAC Latest Developments
Table 123. Tiankang Biopharmacuetical Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 125. Tiankang Biopharmacuetical Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Tiankang Biopharmacuetical Main Business
Table 127. Tiankang Biopharmacuetical Latest Developments
Table 128. Vetal Company Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 129. Vetal Company Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 130. Vetal Company Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Vetal Company Main Business
Table 132. Vetal Company Latest Developments
Table 133. Veterinary Research Institute Basic Information, Sheep and Goat Pox Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 134. Veterinary Research Institute Sheep and Goat Pox Vaccines Product Portfolios and Specifications
Table 135. Veterinary Research Institute Sheep and Goat Pox Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Veterinary Research Institute Main Business
Table 137. Veterinary Research Institute Latest Developments
List of Figures
Figure 1. Picture of Sheep and Goat Pox Vaccines
Figure 2. Sheep and Goat Pox Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sheep and Goat Pox Vaccines Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Sheep and Goat Pox Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sheep and Goat Pox Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Live Vaccines
Figure 10. Product Picture of Killed Vaccines
Figure 11. Global Sheep and Goat Pox Vaccines Sales Market Share by Type in 2022
Figure 12. Global Sheep and Goat Pox Vaccines Revenue Market Share by Type (2018-2023)
Figure 13. Sheep and Goat Pox Vaccines Consumed in Sheep
Figure 14. Global Sheep and Goat Pox Vaccines Market: Sheep (2018-2023) & (K Units)
Figure 15. Sheep and Goat Pox Vaccines Consumed in Goat
Figure 16. Global Sheep and Goat Pox Vaccines Market: Goat (2018-2023) & (K Units)
Figure 17. Global Sheep and Goat Pox Vaccines Sales Market Share by Application (2022)
Figure 18. Global Sheep and Goat Pox Vaccines Revenue Market Share by Application in 2022
Figure 19. Sheep and Goat Pox Vaccines Sales Market by Company in 2022 (K Units)
Figure 20. Global Sheep and Goat Pox Vaccines Sales Market Share by Company in 2022
Figure 21. Sheep and Goat Pox Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Sheep and Goat Pox Vaccines Revenue Market Share by Company in 2022
Figure 23. Global Sheep and Goat Pox Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Sheep and Goat Pox Vaccines Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Sheep and Goat Pox Vaccines Sales 2018-2023 (K Units)
Figure 26. Americas Sheep and Goat Pox Vaccines Revenue 2018-2023 ($ Millions)
Figure 27. APAC Sheep and Goat Pox Vaccines Sales 2018-2023 (K Units)
Figure 28. APAC Sheep and Goat Pox Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. Europe Sheep and Goat Pox Vaccines Sales 2018-2023 (K Units)
Figure 30. Europe Sheep and Goat Pox Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Sheep and Goat Pox Vaccines Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Sheep and Goat Pox Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Americas Sheep and Goat Pox Vaccines Sales Market Share by Country in 2022
Figure 34. Americas Sheep and Goat Pox Vaccines Revenue Market Share by Country in 2022
Figure 35. Americas Sheep and Goat Pox Vaccines Sales Market Share by Type (2018-2023)
Figure 36. Americas Sheep and Goat Pox Vaccines Sales Market Share by Application (2018-2023)
Figure 37. United States Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Sheep and Goat Pox Vaccines Sales Market Share by Region in 2022
Figure 42. APAC Sheep and Goat Pox Vaccines Revenue Market Share by Regions in 2022
Figure 43. APAC Sheep and Goat Pox Vaccines Sales Market Share by Type (2018-2023)
Figure 44. APAC Sheep and Goat Pox Vaccines Sales Market Share by Application (2018-2023)
Figure 45. China Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Sheep and Goat Pox Vaccines Sales Market Share by Country in 2022
Figure 53. Europe Sheep and Goat Pox Vaccines Revenue Market Share by Country in 2022
Figure 54. Europe Sheep and Goat Pox Vaccines Sales Market Share by Type (2018-2023)
Figure 55. Europe Sheep and Goat Pox Vaccines Sales Market Share by Application (2018-2023)
Figure 56. Germany Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Sheep and Goat Pox Vaccines Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Sheep and Goat Pox Vaccines Sales Market Share by Application (2018-2023)
Figure 65. Egypt Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Sheep and Goat Pox Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Sheep and Goat Pox Vaccines in 2022
Figure 71. Manufacturing Process Analysis of Sheep and Goat Pox Vaccines
Figure 72. Industry Chain Structure of Sheep and Goat Pox Vaccines
Figure 73. Channels of Distribution
Figure 74. Global Sheep and Goat Pox Vaccines Sales Market Forecast by Region (2024-2029)
Figure 75. Global Sheep and Goat Pox Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Sheep and Goat Pox Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Sheep and Goat Pox Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Sheep and Goat Pox Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Sheep and Goat Pox Vaccines Revenue Market Share Forecast by Application (2024-2029)
  • Global Classical Swine Fever Vaccines Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 100
    It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of The genus Pestivirus of The family Flaviviridae, and is closely related to The viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV). The global Classical Swine Fever Vaccines market was valued at US$ 154.7 million in 2023 and is anticipa......
  • Global Tylosin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Tylosin market size was valued at US$ 674.4 million in 2023. With growing demand in downstream market, the Tylosin is forecast to a readjusted size of US$ 909 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Tylosin market. Tylosin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chai......
  • Global Animal Parasiticides Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106
    According to our LPI (LP Information) latest study, the global Animal Parasiticides market size was valued at US$ 6898.6 million in 2023. With growing demand in downstream market, the Animal Parasiticides is forecast to a readjusted size of US$ 9363.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Animal Parasiticides market. Animal Parasiticides are expected to show stable growth in the future market. However, ......
  • Global Newcastle Disease Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Newcastle Disease Vaccine market size was valued at US$ 308 million in 2023. With growing demand in downstream market, the Newcastle Disease Vaccine is forecast to a readjusted size of US$ 389.8 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Newcastle Disease Vaccine market. Newcastle Disease Vaccine are expected to show stable growth in the future m......
  • Global Classical Swine Fever Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 126
    According to our LPI (LP Information) latest study, the global Classical Swine Fever Vaccines market size was valued at US$ 151.4 million in 2023. With growing demand in downstream market, the Classical Swine Fever Vaccines is forecast to a readjusted size of US$ 209.8 million by 2030 with a CAGR of 4.8% during review period. The research report highlights the growth potential of the global Classical Swine Fever Vaccines market. Classical Swine Fever Vaccines are expected to show stable ......
  • Global Veterinary Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Veterinary Vaccine market size was valued at US$ 10570 million in 2023. With growing demand in downstream market, the Veterinary Vaccine is forecast to a readjusted size of US$ 17200 million by 2030 with a CAGR of 7.2% during review period. The research report highlights the growth potential of the global Veterinary Vaccine market. Veterinary Vaccine are expected to show stable growth in the future market. However, product di......
  • Global Foot and Mouth Disease (FMD) Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Foot and Mouth Disease (FMD) Vaccines market size was valued at US$ 895.6 million in 2023. With growing demand in downstream market, the Foot and Mouth Disease (FMD) Vaccines is forecast to a readjusted size of US$ 1644.2 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Foot and Mouth Disease (FMD) Vaccines market. Foot and Mouth Disease (FMD) Vaccines......
  • Global Veterinary Products for Companion Animals Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Veterinary Products for Companion Animals market size was valued at US$ 15190 million in 2023. With growing demand in downstream market, the Veterinary Products for Companion Animals is forecast to a readjusted size of US$ 22710 million by 2030 with a CAGR of 5.9% during review period. The research report highlights the growth potential of the global Veterinary Products for Companion Animals market. Veterinary Products for Co......
  • Global Newcastle Disease Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 115
    According to our (Global Info Research) latest study, the global Newcastle Disease Vaccine market size was valued at USD 323.9 million in 2023 and is forecast to a readjusted size of USD 402.7 million by 2030 with a CAGR of 3.2% during review period. Newcastle disease is a contagious viral bird disease affecting many domestic and wild avian species; it is transmissible to humans. Newcastle disease can be controlled by the use of vaccines. There are many Newcastle disease vaccines s......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs